Ruixue Zhou Selected Research

Non-Receptor Type 6 Protein Tyrosine Phosphatase

1/2020

SHP-1 suppresses the antiviral innate immune response by targeting TRAF3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruixue Zhou Research Topics

Disease

3	Infections 10/2023 - 01/2021
2	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2020
1	Mental Disorders (Mental Disorder) 05/2024
1	Osteomyelitis 10/2023
1	Pneumonia (Pneumonitis) 10/2023
1	Amebiasis (Amoebiasis) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Colitis 01/2019
1	Hemolytic-Uremic Syndrome 01/2019

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
1	Mitochondrial DNA (mtDNA)IBA 05/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2023
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2023
1	ZincIBA 01/2022
1	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Interferon Type IIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	beta-Arrestin 1IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	MitogensIBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019

Therapy/Procedure

1	Therapeutics 01/2022